A detailed history of Pictet Asset Management Holding Sa transactions in Immunovant, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,174,816 shares of IMVT stock, worth $32.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,174,816
Previous 1,265,298 7.15%
Holding current value
$32.3 Million
Previous $40.9 Million 24.13%
% of portfolio
0.04%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.1 - $31.61 $2.27 Million - $2.86 Million
-90,482 Reduced 7.15%
1,174,816 $31 Million
Q1 2024

May 14, 2024

SELL
$30.27 - $43.79 $1.28 Million - $1.85 Million
-42,133 Reduced 3.22%
1,265,298 $40.9 Million
Q4 2023

Feb 13, 2024

BUY
$31.31 - $44.19 $5.39 Million - $7.61 Million
172,226 Added 15.17%
1,307,431 $55.1 Million
Q3 2023

Nov 14, 2023

BUY
$18.55 - $39.96 $21.1 Million - $45.4 Million
1,135,205 New
1,135,205 $43.6 Million

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.